Scorpion venom research company did not commit misconduct, B.C. regulator rules
A Vancouver-based health sciences company that was attempting to develop synthetic scorpion venom withheld relevant information from investors, but that omission did not necessarily have an impact on the company's stock price, B.C.'s financial regulator has ruled.
A panel of the B.C. Securities Commission dismissed the allegations against PreveCeutical Medical Inc. and its CEO Stephen Van Deventer in a decision issued this week.
The commission's executive director had accused PreveCeutical and Van Deventer of misconduct stemming from a news release the company issued in 2018. In the release, the company said it had raised approximately $6.5 million through a private placement, but it did not share that approximately $3.2 million of the total had already been paid or would be paid to consultants.
Panels of the BCSC have found these types of omissions to be misconduct in the past, such as when a blockchain company failed to disclose it would be paying most of the $5.4 million it had raised to consultants.
In this case, however, the panel found that PreveCeutical's omission, while misleading, did not necessarily constitute a "material" omission that would have a significant effect on the company's market value.
"The executive director must prove on a balance of probabilities not simply that investors were misled, but also that the impact would have been sufficiently serious from the point of view of reasonable investors that the effect on market price would have been significant," the panel explains in its decision.
The panel concluded that this was "an open question" in the case of PreveCeutical's news release, in part because the company had previously disclosed publicly that only about 10 per cent of its available funds were being spent on research and development.
Reasonable investors would have felt they weren't given all of the necessary facts in the news release, the panel found, but that doesn't necessarily mean there would be a significant effect on share prices.
"Although the executive director has come close, the evidence introduced before us has not established on a balance of probabilities that the omission which has been proven was material in the sense required by the relevant provisions of the (Securities) Act," the decision reads.
For this reason, the panel dismissed the allegations against PreveCeutical and Van Deventer.
CTVNews.ca Top Stories
Ontario patients visiting emergency rooms out of fear being booted by family doctor
Ontario patients are now visiting emergency departments out of fear of being de-rostered from their doctor’s office – a loophole that results in hospitals dealing with non-urgent cases, and disrupts continuity of care paramount to family medicine, according to health-care experts.
Putin wants Ukraine ceasefire on current frontlines, Reuters sources say
Russian President Vladimir Putin is ready to halt the war in Ukraine with a negotiated ceasefire that recognizes the current battlefield lines, four Russian sources told Reuters, saying he is prepared to fight on if Kyiv and the West do not respond.
Outdated rules and mounting losses: Can anything be done to fix Canada Post?
Canada Post needs drastic measures to staunch the fiscal bleeding and revamp its operations after a tough decade, experts say.
American Airlines retreats after blaming a 9-year-old for not seeing a hidden camera in a lavatory
American Airlines has distanced itself from a court filing in which the carrier said a nine-year-old girl should have noticed there was a camera taped to the seat of an airplane lavatory.
What is 'slapped cheek disease' and should parents be concerned?
Despite its rough name, experts say most cases of 'slapped cheek disease' are mild and not a cause for concern.
Trillions of cicadas are emerging in the U.S. Here's what they sound like
Two broods of periodical cicadas are emerging in the United States simultaneously for the first time since 1803. Here is what their deafening buzz sounds like.
Ontario mother denied boarding flight with her family after ticket mistake
A dream vacation for an Ontario family quickly turned to frustration when a mother’s name on a ticket didn’t match the name on her passport, meaning she was left behind while her husband and two children flew to France.
Competition Bureau probes alleged anticompetitive conduct by Loblaws, Sobeys owners
Canada's Competition Bureau has launched investigations into the parent companies of grocery chains Loblaws and Sobeys for alleged anticompetitive conduct, court documents reveal, with Sobeys' owner calling the inquiry 'unlawful.'
A deep-dive into a failed 'Star Wars' hotel is going viral
In 2023, Disney closed a highly-publicized luxury hotel on the Walt Disney World property called 'Star Wars: Galactic Starcruiser.' Now, a year later, a four-hour-long YouTube deep-dive has resurfaced details about the concept and spread the niche piece of Disney lore to millions of viewers.